In a letter submitted to the House Energy and Commerce Subcommittee on Oversight and Investigations for a hearing on challenges implementing value-based and alternative payment models under the Medicare Access and CHIP Reauthorization Act of 2015, AHA encouraged certain statutory and regulatory policies to advance and flexibly implement these models. Recommendations include extending incentive payments; investing in resources and infrastructure to support rural hospitals’ transition to APMs; improving cost measures in the Merit-based Incentive Payment System; and supporting more gradual transitions to risk for certain Medicare Shared Savings Program accountable care organizations.  
 
“One additional factor that has impacted the transition to value-based care has been the longstanding challenges with insufficient reimbursement,” AHA said, including site-neutral payment cuts that have contributed to Medicare’s “chronic failure to cover the cost of caring for its beneficiaries.” The association said it “strongly opposes additional site-neutral payment cuts, which threaten access to care.”  

Related News Articles

Perspective
Public
More than 34.1 million Americans were enrolled in a Medicare Advantage plan in 2025, accounting for 54% of all Medicare beneficiaries. We have seen enrollment…
Headline
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart…
Headline
The Coalition to Strengthen America’s Healthcare Feb. 5 released a new research brief examining the impact of proposed site-neutral payment policies on…
Headline
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and…
Blog
Public
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…